STAT3 and neoplasm: Genomic studies have shown that gain of function point mutations and copy number gains in this pathway are frequent and correlate with gene expression of STAT3 and increased expression of pro-inflammatory cytokines IL17 and IL22, downstream targets of STAT3 activation that likely play a role in tumor progression (25, 63).